AETNOTCMiscellaneous Electrical Machinery, Equipment & SuppliesUS GAAP · USD

Aeternum Health, Inc.

Aeternum Health, Inc. is a U.S.-based public company with limited disclosed operating detail in the available filings. The company’s reported activity suggests a small corporate structure that has issued equity and capitalized software-related intangible assets as part of its business development.

Revenue0.2m USD
+212.7 %y/y
Operating profit (EBIT)-0.3m USD
+37.4 %y/y
EBIT margin-132.2%
+528.8 ppy/y
Net income-0.3m USD
+25.1 %y/y

Fiscal year 2025 · change from previous year

Development 2021–2025

-0.6-0.4-0.20.00.20.4m USD2021: EBIT -0.03 m USD20212022: 0.01 m USD2022: EBIT -0.30 m USD20222023: 0.02 m USD2023: EBIT -0.55 m USD20232024: 0.07 m USD2024: EBIT -0.43 m USD20242025: 0.20 m USD2025: EBIT -0.27 m USD20250.20-0.27
RevenueOperating profit (EBIT)

Business

Share of revenue
Software and intangible assets0 %

Capitalized software or software-related assets used in the company’s operations.

Equity-funded corporate activities0 %

Issuance of common stock and stock-based consideration used to support operations.

Administrative and development activities100 %

General company-level activities supporting business formation and execution.

Products

Reported · share of revenue
57.6%35.1%FY2025100 %
  • Products57.6 %
  • Services35.1 %
  • Power Usage Revenue7.3 %

Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.

Customers

The available filings do not disclose a commercial customer base, product end markets, or recurring sales channels. Based on the reported transactions, the company appears to be in an early corporate development stage where counterparties include software vendors, service providers, and financing participants rather than a broad operating customer base.

Software vendor / technology supplier

Receives equity consideration for software or related assets used by the company.

Service providers

Provide services compensated with stock-based awards or equity issuances.

Equity investors and funding counterparties

Buy common stock to provide cash for operating expenses and corporate needs.

Strategy

The disclosed activity points to a strategy of funding operations through equity issuances while building out software-related assets. Capitalizing software purchases and compensating services with stock suggest a focus on preserving cash while developing the company’s operating platform.

Preserve cash through equity-based fundingShort term

The company has used common stock sales and stock compensation to support expenses.

Develop software-related assetsMedium term

Capitalized software can support future operations and product development.

Geography

The company is based in the United States, and the available filings do not disclose meaningful international operations or revenue geography. With no reported country-level sales or operating footprint in the excerpts, the business appears to be primarily U.S.-centric at this stage.

Risks

The main risks are typical of a small development-stage public company: dependence on external funding, limited operating disclosure, and uncertainty around the value of capitalized software assets. Because the company appears to have little disclosed revenue activity, execution risk and dilution risk are likely more important than traditional operating margin risks.

Sorted by severity
Financing dependenceHigh

The company has relied on stock sales to pay expenses, indicating ongoing need for external capital.

Exposure: Corporate operating funding

Dilution riskHigh

Repeated common stock issuances can reduce existing shareholders' ownership and per-share value.

Exposure: Equity structure

Intangible asset impairmentMedium

Capitalized software must continue to provide economic benefit or it may require write-downs.

Exposure: Software-related intangible assets

Accounting

Judgemental items
Capitalized software intangible assets

Software acquired with shares was recorded as an intangible asset, affecting asset values and future amortization or impairment.

Impact: Balance sheet and future earnings

Stock-based compensation

Shares granted for services create non-cash expense based on fair value at grant date.

Impact: Operating expenses and equity

Equity issuance accounting

Common stock sales and related-party issuances affect paid-in capital and dilution analysis.

Impact: Equity and per-share metrics

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026